European regulators endorse Lilly’s Alzheimer’s treatment for certain patients The medicine, called Kisunla, was shown to slow patients’ decline, but comes with side effect concerns

https://www.statnews.com/2025/07/25/europe-eli-lilly-kisunla-alzheimers-aria-approval/